title: Lanthanum carbonate and peritoneal catheter dysfunction.
authors.forename: José R
authors.initials: JR
authors.lastname: Rodríguez-Palomares
authors.forename: Gabriel
authors.initials: G
authors.lastname: de Arriba
authors.forename: Liliana
authors.initials: L
authors.lastname: Gómez
authors.forename: Katia
authors.initials: K
authors.lastname: Pérez
authors.forename: Mariángeles
authors.initials: M
authors.lastname: Basterrechea
authors.forename: Beatriz
authors.initials: B
authors.lastname: Hernández
authors.forename: Serafín
authors.initials: S
authors.lastname: Tallón
mesh_terms: D057785:Catheters / Q000009:adverse effects*; D002614:Chelating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003248:Constipation / Q000139:chemically induced* / Q000150:complications / Q000000981:diagnostic imaging; D004868:Equipment Failure; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy / Q000209:etiology; D054559:Hyperphosphatemia / Q000188:drug therapy / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000601:surgery / Q000628:therapy; D016030:Kidney Transplantation; D007811:Lanthanum / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000295:instrumentation*; D011183:Postoperative Complications / Q000188:drug therapy; D055031:Primary Graft Dysfunction; D011859:Radiography
chemical_list: D002614:Chelating Agents; C028521:lanthanum chloride; D007811:Lanthanum